verified SJR 1,226 · Q2 • database Scopus / SJR & Web of Science indexed

Greece · Spandidos Publications

workspace_premium Q2 — Oncology lock Subscription

International Journal of Oncology

International Journal of Oncology is a journal indexed in SJR in Oncology and Cancer Research with an H index of 142. It has an SJR impact factor of 1,226 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 1,226.

International Journal of Oncology focuses its scope in these topics and keywords: cancer, human, activity, cells, tumor, tlr, cell, breast, apoptosis, anticancer, ...

ISSN: 1019-6439

Publisher: Spandidos Publications

Category: Oncology

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

1,226 Q2

H-index 142

Acceptance rate pie_chart

23% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

NPD Subscription

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

1,226

H-index

142

Docs (year)

116

Docs 3y

419

Total refs

11414

Cites 3y

1890

Citable 3y

418

Cites/Doc 2y

4.19

Ref/Doc

98.4

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Aquaporin expression in breast cancer and their involvement in bleb formation, cell motility and invasion in endocrine resistant variant cells

Viral infections as a cause of cancer (Review)

Establishment and characterization of a cisplatin-resistant cell line, KB-R, derived from oral carcinoma cell line, KB

DSCP1, a novel TP53-inducible gene, is upregulated by strong genotoxic stresses and its overexpression inhibits tumor cell growth in vitro

Down-regulation of miR-221 and miR-222 correlates with pronounced Kit expression in gastrointestinal stromal tumors

Docosahexaenoic acid inhibits the invasion of MDA-MB-231 breast cancer cells through upregulation of cytokeratin-1

Differential transferrin receptor density in human colorectal cancer: A potential probe for diagnosis and therapy.

Differential roles of Src in transforming growth factor-beta regulation of growth arrest, epithelial-to-mesenchymal transition and cell migration in pancreatic ductal adenocarcinoma cells

Development of a drug resistance model for hepatoblastoma

Comparison of peptide cancer signatures identified by mass spectrometry in serum of patients with head and neck, lung and colorectal cancers: Association with tumor progression

Combined therapy with a thymidylate synthase-inhibiting vector and S-1 has effective antitumor activity against 5-FU-resistant tumors

Cancer-associated fibroblasts from invasive breast cancer have an attenuated capacity to secrete collagens

SHOW MORE ARTICLES

Bufotalin sensitizes death receptor-induced apoptosis via Bid- and STAT1-dependent pathways

A natural anti-inflammatory enone fatty acid inhibits angiogenesis by attenuating nuclear factor-?e¬?B signaling in vascular endothelial cells

Apoptosis induction by glycoprotein isolated from Laminaria japonica is associated with down-regulation of telomerase activity and prostaglandin E2 synthesis in AGS human gastric cancer cells

Antitumor effect of endostatin overexpressed in C6 glioma cells is associated with the down-regulation of VEGF

Antiproliferative activity of di-2-pyridylhydrazone dithiocarbamate acetate partly involved in p53 mediated apoptosis and autophagy

Andrographolide induces apoptosis in human osteosarcoma cells via the ROS/JNK pathway

An expression study of hormone receptors in spontaneously developed, carcinogen-induced and hormone-induced mammary tumors in female Noble rats

Altered expression of TGFB receptors and mitogenic effects of TGFB in pancreatic carcinomas

Age-related alterations in 32P-postlabeled DNA adducts in livers of mice infected with the tumorigenic bacterial pathogen, Helicobacter hepaticus.

Agaricus blazei Murill enhances doxorubicin-induced apoptosis in human hepatocellular carcinoma cells by NF?e¬?B-mediated increase of intracellular doxorubicin accumulation

Activin A enhances MMP-7 activity via the transcription factor AP-1 in an esophageal squamous cell carcinoma cell line

Abnormal expression of FOSB correlates with tumor progression and poor survival in patients with gastric cancer

FAQs

International Journal of Oncology has an SJR of 1,226 (best quartile Q2) in the CountryOfPapers database.

Immediate OA APC is not available (NPD).

The acceptance rate recorded for International Journal of Oncology is 23%.

International Journal of Oncology

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of International Journal of Oncology?

What is the APC / publication cost?

What is the acceptance rate?